Dannex Ayrton Starwin Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Daniel Kwabena Kissi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO
Daniel Kwabena Kissi (56 yo)
no data
Tenure
Mr. Daniel Kwabena Apeagyei Kissi has been Managing Director of Ayrton Drugs Manufacturing Company Ltd. since December 01, 2012 and also it's Chief Executive Officer. He has been Chief Executive Officer an...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | no data | no data | no data | |
| CEO & Executive Director | no data | no data | no data | |
| CFO & Executive Director | 2.5yrs | no data | no data | |
| Chief Corporate Affairs & Communications Officer and Non-Executive Director | 2.5yrs | no data | no data | |
| Non-Executive Director | no data | no data | no data | |
| Non-Executive Director | no data | no data | no data | |
| Non-Executive Director | no data | no data | 3.78% GHS 0 | |
| Non-Executive Director | 2.5yrs | no data | no data | |
| Non-Executive Director | 1.4yrs | no data | no data |
2.5yrs
Average Tenure
72yo
Average Age
Experienced Board: DASPHARMA's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.